Glecirasib (Compound 1-2, JAB-21822) is an orally active and potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. Glecirasib has the potential for the research of KRAS G12C-mediated cancer[1][2][3][4].
Molecular Weight:
640.03
Purity:
99.20
CAS Number:
[2657613-87-9]
Formula:
C31H26ClF4N7O2
Target:
Ras
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted